quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:28·23d
SECFiling
Forte Biosciences Inc. logo

SEC Form 10-K filed by Forte Biosciences Inc.

FBRX· Forte Biosciences Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • FBRX
    Forte Biosciences Inc.
    Health Care

Recent analyst ratings

  • Nov 25UpdateEvercore ISI$65.00
  • Aug 18UpdateGuggenheim$75.00
  • Jan 21UpdateTD Cowen-
  • Apr 8UpdateLadenburg Thalmann$2.75
  • Sep 20UpdateChardan Capital Markets$3.50
  • Sep 20UpdateChardan Capital$3.50

Related

  • SEC14d
    SEC Form 424B5 filed by Forte Biosciences Inc.
  • SEC15d
    SEC Form 8-K filed by Forte Biosciences Inc.
  • PR15d
    Forte Biosciences Announces Pricing of $150 Million Public Offering
  • SEC15d
    SEC Form 424B5 filed by Forte Biosciences Inc.
  • PR15d
    Forte Biosciences Announces Proposed Public Offering
  • INSIDER20d
    SEC Form 4 filed by Riley Antony A
  • INSIDER20d
    SEC Form 4 filed by Wagner Paul A.
  • SEC23d
    Forte Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022